These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3035355)

  • 1. [New views on lipoprotein metabolism].
    Lepsanović L; Lepsanović L
    Med Pregl; 1986; 39(9-10):457-63. PubMed ID: 3035355
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular basis of atherosclerosis: concepts derived from studies of lipoprotein metabolism and cell biology.
    Mahley RW
    Clin Invest Med; 1986 Nov; 9(4):304-8. PubMed ID: 3026707
    [No Abstract]   [Full Text] [Related]  

  • 3. [Lipoprotein metabolism and atherosclerosis].
    Pometta D; James R
    Schweiz Rundsch Med Prax; 1988 Jun; 77(24):664-8. PubMed ID: 2840728
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipoprotein receptors and atheromatosis].
    Masana Marín L
    Med Clin (Barc); 1984 Jun; 83(3):119-21. PubMed ID: 6090823
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic factors influencing lipoprotein structure: implications for atherosclerosis.
    Chan L; Dresel HA
    Lab Invest; 1990 May; 62(5):522-37. PubMed ID: 2160560
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular metabolism of apoprotein-B containing lipoproteins: the role of apoproteins, heparan sulfate and cellular receptors.
    Sehayek E
    Isr J Med Sci; 1996 Jun; 32(6):445-8. PubMed ID: 8682649
    [No Abstract]   [Full Text] [Related]  

  • 7. [Disorders of lipoprotein metabolism. I. The physiopathology].
    Ahumada Ayala M
    Arch Inst Cardiol Mex; 1991; 61(1):79-91. PubMed ID: 1646588
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cell receptors for lipoproteins and their regulation].
    Polonovski J; Mazière JC; Mazière C; Goldstein S; Gardette J
    Bull Acad Natl Med; 1985 Jun; 169(6):747-59. PubMed ID: 3002562
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipoprotein receptors and dyslipoproteinemias].
    Orbetsova V
    Vutr Boles; 1984; 23(3):1-7. PubMed ID: 6087571
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of lipoprotein receptors in lipid transport and in the pathogenesis of the hyperlipoproteinemias.
    Chait A
    Spec Top Endocrinol Metab; 1983; 5():1-53. PubMed ID: 6322371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism of lipoproteins: role of specific receptors].
    Mathé D; Guettet C; Lecuyer B; Jacotot B
    Journ Annu Diabetol Hotel Dieu; 1987; ():7-21. PubMed ID: 3039230
    [No Abstract]   [Full Text] [Related]  

  • 12. [Receptors in lipoprotein metabolism].
    Steinmetz A; Utermann G
    Internist (Berl); 1988 Jun; 29(6):372-89. PubMed ID: 2841254
    [No Abstract]   [Full Text] [Related]  

  • 13. Disorders of lipid transport: relationship to abnormalities of apoproteins, enzymes and cellular receptors.
    Schonfeld G
    Prog Clin Biol Res; 1984; 147():375-402. PubMed ID: 6330755
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies.
    Daugherty A; Roselaar SE
    Cardiovasc Res; 1995 Mar; 29(3):297-311. PubMed ID: 7781006
    [No Abstract]   [Full Text] [Related]  

  • 15. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)].
    Krempler F
    Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine models for study of lipoprotein metabolism and atherosclerosis.
    Witztum JL
    J Clin Invest; 1993 Aug; 92(2):536-7. PubMed ID: 8349795
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of hepatic and lipoprotein lipase in lipoprotein metabolism and atherosclerosis: studies in transgenic and knockout animal models and somatic gene transfer.
    Santamarina-Fojo S; Haudenschild C
    Int J Tissue React; 2000; 22(2-3):39-47. PubMed ID: 10937353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes].
    Kulikov VI; Bergel'son LD
    Biokhimiia; 1984 Aug; 49(8):1310-5. PubMed ID: 6093897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small dense low density lipoprotein: formation and potential mechanisms for atherogenicity.
    Deckelbaum RJ; Galeano NF
    Isr J Med Sci; 1996 Jun; 32(6):464-8. PubMed ID: 8682652
    [No Abstract]   [Full Text] [Related]  

  • 20. [Metabolism of atherogenic lipoproteins].
    Beucler I; Turpin G
    Ann Med Interne (Paris); 2001 Apr; 152(3):158-61. PubMed ID: 11431574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.